Company Information

Company name Aptahem AB
Business idea Aptahem AB is a biotechnology company whose business concept is to develop aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company also carries out business development work towards future partners and licensees. The company’s main candidate, Apta-1, is developed as an emergency drug designed to prevent the progression of life-threatening organ- and tissue damages in sepsis patients.
CEO Mikael Lindstam
Chairman of the Board Kjell G Stenberg
Board of directors Kjell G Stenberg Johan Lindh Cristina Glad Theresa Comiskey Olsen Mikael Lindstam
Number of employees 6
Organisation number 556970-5782
Article of association Bolagsordning 2017-06-07
Address Norra Vallgatan 58, 4 tr
Zip code 211 22
City Malmö
Website www.aptahem.com
E-mail info@aptahem.com
Phone 0766 – 33 36 99